|
|
||||
 | ||||
|
|
Select from the search options to widen or narrow the search results. Z1071 is a single arm Phase II Surgical Study. The purpose of the study is to evaluate sentinel lymph node (SLN) surgery as an alternative to axillary lymph node dissection (ALND) for axillary staging after preoperative chemotherapy for nodal disease and invasive breast cancer. The study will primarily try to determine the false negative rate for SLN surgery. There are an additional four secondary objectives that try to determine various aspects of nodal status post chemotherapy. All subjects will receive axillary ultrasound, plus SLN and ALND, after completing preoperative therapy. The subjects will be followed post-operatively for relapse and survival every 6-months for 2 years, then every year for 2 years, then every other year for 6 years (total of 10 years). The primary investigator is Wendy Mikkelson, MD. The study coordinator is Carol Davis, RN, BSN, CCRC. The study coordinator can be reached at 414-649-5608 for more information. The study is expected to be enrolling and available at Aurora St. Luke's, Sinai, and West Allis Medical Centers until the year 2013. Clinical trial location(s)Aurora Sinai Medical Center945 North 12th Street Milwaukee, WI 53233 Aurora St. Luke's Medical Center
[ previous page ]
|
||
 |
||||
 |
 |
 |
|
 |
